Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Urothelial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07087860
What this trial is testing

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis and Ureter Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+3 more
Mayo Clinic 70
Large-scale testing (Phase 3)UnknownNCT00553124
What this trial is testing

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Who this might be right for
Bladder Cancer
University Hospital Birmingham 3,400
Testing effectiveness (Phase 2)Looking for participantsNCT07647289
What this trial is testing

EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)
Peking University Third Hospital 58
Testing effectiveness (Phase 2)Study completedNCT01599013
What this trial is testing

JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin

Who this might be right for
Bladder Transitional Cell Carcinoma Stage IV
Pierre Fabre Medicament 69
Large-scale testing (Phase 3)Active Not RecruitingNCT03091660
What this trial is testing

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

Who this might be right for
Stage 0 Bladder Urothelial CarcinomaStage 0is Bladder Urothelial CarcinomaStage I Bladder Urothelial Carcinoma
SWOG Cancer Research Network 1,000
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Early research (Phase 1)Ended earlyNCT06630247
What this trial is testing

A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid CancersSolid Tumor CancerSolid Tumor Malignancy+4 more
Exelixis 9
Testing effectiveness (Phase 2)Study completedNCT01520038
What this trial is testing

Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer

Who this might be right for
Urothelial Carcinoma of the Bladder
Abramson Cancer Center at Penn Medicine 2
Large-scale testing (Phase 3)Active Not RecruitingNCT02951325
What this trial is testing

Bladder Cancer Adjuvant Radiotherapy Trial

Who this might be right for
Bladder CancerUrothelial Carcinoma Bladder
Tata Memorial Centre 153
Not applicableActive Not RecruitingNCT05080998
What this trial is testing

Longitudinal Bladder Cancer Study for Tumour Recurrence

Who this might be right for
Urothelial Bladder Cancer
Pacific Edge Limited 450
Testing effectiveness (Phase 2)UnknownNCT03549715
What this trial is testing

NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma

Who this might be right for
Infiltrating Bladder Urothelial Carcinoma
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 121
Not applicableUnknownNCT04588168
What this trial is testing

Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma

Who this might be right for
Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 100
Testing effectiveness (Phase 2)Study completedNCT02387996
What this trial is testing

Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 270
Early research (Phase 1)Study completedNCT01878188
What this trial is testing

Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma

Who this might be right for
Transitional Cell Carcinoma of Bladder
Anchiano Therapeutics Israel Ltd. 38
Very early researchNot Yet RecruitingNCT07272603
What this trial is testing

Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Qilu Hospital of Shandong University 5
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Early research (Phase 1)Study completedNCT00694798
What this trial is testing

Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder

Who this might be right for
Bladder Cancer
Cadila Pharnmaceuticals 22
Testing effectiveness (Phase 2)WithdrawnNCT06424717
What this trial is testing

Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)

Who this might be right for
Urothelial Carcinoma
EMD Serono Research & Development Institute, Inc.
Not applicableWithdrawnNCT01060319
What this trial is testing

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

Who this might be right for
Bladder CancerSkin CancersBladder (Urothelial, Transitional Cell) Cancer+1 more
Stanford University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03609216
What this trial is testing

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Who this might be right for
Infiltrating Bladder Urothelial CarcinomaStage II Bladder Urothelial CarcinomaStage III Bladder Urothelial Carcinoma
Alliance for Clinical Trials in Oncology 237
Next Page